Welcome to Prospect! We use the same data as VCs to help you find the best startups and understand what your equity is likely to be worth.
View more companies

Augury

Augury provides AI-driven Machine and Process Health solutions, using wireless sensors and predictive analytics to reduce industrial equipment downtime.

Secondary Market Price

Updated: 
Jan 2026
Current Preferred Price
Date:
Sign in to view
Prospect Projected Preferred
Current FMV
Date:
Sign in to view
Prospect Projected FMV
$1.2B
Company Valuation
Updated: 
Jan 2026
AI
Industry
New York, NY
Headquarters
2011
Year Founded
360+
Employee Count

How Augury Measures Up

To help you manage your Augury equity, Prospect has run the company through our machine learning model.

Prospect Rating

--

This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.

Exit Risk

--

Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.

Funding Stage

Series F

A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.

Est val $1.2B
--
Jan 28, 2026

Create a free account to unlock real-time secondary market prices and future projections of Augury's value.

Sign up to Unlock the Latest Data
Failed to load data. Using sample data.
Loading chart…

Data will be available soon.
Sign up to receive notifications when it is available.

Sign up to get notified
Sign up to Unlock the Latest Data

Prospect Projected Future Augury Prices

Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Augury's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description

Augury provides Machine Health and Process Health solutions for industrial and manufacturing clients. Using wireless sensors and artificial intelligence, the company offers predictive and prescriptive analytics for industrial equipment to help reduce production downtime, improve process efficiency, and lower waste. It serves global customers in sectors including food and beverage, chemicals, and pharmaceuticals. Founded in 2011 by Saar Yoskovitz and Gal Shaul, Augury is headquartered in New York and maintains offices in Israel. The company has raised $294 million in total funding, with its most recent round being a Series F in March 2025, and has grown in part through acquisitions, such as its merger with Seebo.

Recent company activities signal a continued focus on expanding its role within the manufacturing industry. Augury held a company-wide meeting in Prague to kick off 2026, aimed at aligning its global teams on collaboration and innovation. The company also maintains a presence at industry-specific events, such as the Dairy Forum. To provide concrete data on its impact, Augury has promoted a Forrester Total Economic Impact (TEI) study that quantifies the business results of its predictive maintenance technology. These efforts support the company's stated goal of using its AI-driven platform to advance productivity and sustainability in industrial settings.

Augury Notable Investors

  • Lightrock
  • Insight Partners
  • Eclipse Ventures
  • Qumra Capital
  • Schneider Electric Ventures
  • Qualcomm Ventures
  • Baker Hughes
  • SE Ventures
  • Munich Re Ventures
  • Lerer Hippeau

Augury Founders

  • Co-Founder, Saar Yoskovitz
  • Co-Founder, Gal Shaul

Peer Group Comparison

Vs Peer Group of >$4B Startups

Frequently Asked Questions

Is Anduril worth joining?

Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.

Is Augury worth joining?

Deciding whether to join Augury requires a careful evaluation of your potential compensation, especially the long-term value of your equity grant. Tools like Prospect can help you model the future value of your stock options and make a more informed career decision.

What should I do with my Augury stock?

The best strategy for your Augury stock depends on your personal financial goals, risk tolerance, and tax situation. Platforms like Prospect provide customized strategies for exercising options and selling shares to help you maximize your returns.

Can you sell Augury stock?

Since Augury is a private company, you can typically only sell shares during company-approved secondary sales, known as tender offers, or after an IPO. Prospect offers tools to help you navigate tender offers and determine which shares are most tax-optimal to sell.

How can I find the value of my Augury stock?

The current value of your private Augury stock is based on its 409A valuation, but its future worth is harder to predict. To get a clearer picture, Prospect uses proprietary models to forecast your equity's potential future value based on market data.

What is Augury's equity worth?

The total worth of your Augury equity depends on the company's current valuation and your specific grant details. To understand what your shares could be worth to you personally after taxes, platforms like Prospect can model different scenarios and tax implications.

What is Augury's stock ticker symbol?

Augury does not have a stock ticker symbol because it is a private company and its shares are not available on public stock exchanges. Financial tools like Prospect are specifically designed to help employees manage equity in pre-IPO companies that lack public tickers.

Can I buy or sell Augury stock?

As an employee, you acquire equity through your compensation package, but you cannot typically buy or sell Augury stock freely as it is a private company. When opportunities to sell arise, such as a tender offer, Prospect provides tools to help you make tax-optimal decisions.

What is the criteria to buy or invest in Augury stock?

Investing in a private company like Augury is typically limited to venture capital firms and accredited investors during specific funding rounds. For employees who receive equity as compensation, Prospect offers services to manage and maximize the value of those holdings.

Ready to unlock insights on top performing startups?
Ready to unlock insights on top performing startups?